The Lancet Oncology
Fecha de publicación: 22 de enero de 2021
DOI: https://doi.org/10.1016/S1470-2045(20)30743-9
Autores: Katie Spencer, PhD , Christopher M Jones, MRCP, Rebecca Girdler, PGCE, Catherine Roe, MSc, Michael Sharpe, BSc, Sarah Lawton, MPH, Louise Miller, MA, Philippa Lewis, FRCR, Mererid Evans, PhD, Prof David Sebag-Montefiore, FRCR, Tom Roques, FRCR, Rebecca Smittenaar, PhD, Prof Eva Morris, PhD
Background: The indirect impact of the COVID-19 pandemic on cancer outcomes is of increasing concern. However, the extent to which key treatment modalities have been affected is unclear. We aimed to assess the impact of the pandemic on radiotherapy activity in England.
Leer más
Comentarios
Para dejar un comentario antes debes iniciar sesión:
¿No tienes una cuenta?
Regístrate a través de éste enlace.